Pulmonary Aterial Hypertension in an Adolescent Treated with Methylphenidate

Abstract

Journal of Child and Adolescent PsychopharmacologyVol. 20, No. 3 Letters to the EditorPulmonary Aterial Hypertension in an Adolescent Treated with MethylphenidateMehmet Goksin Karaman, Figen Atalay, Ali Evren Tufan, and Ayten ErdoganMehmet Goksin KaramanZonguldak Karaelmas University Medical Faculty, Department of Child and Adolescent Psychiatry, Zonguldak, Turkey.Search for more papers by this author, Figen AtalayZonguldak Karaelmas University Medical Faculty, Department of Child and Adolescent Psychiatry, Zonguldak, Turkey.Search for more papers by this author, Ali Evren TufanDepartment of Child and Adolescent Psychiatry, Elazig Hospital for Mental Disorders, Elazig, Turkey.Search for more papers by this author, and Ayten ErdoganZonguldak Karaelmas University Medical Faculty, Department of Child and Adolescent Psychiatry, Zonguldak, Turkey.Search for more papers by this authorPublished Online:26 Jun 2010https://doi.org/10.1089/cap.2009.0095AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byA second hit? Pulmonary arterial hypertension, BMPR2 mutation, and exposure to prescription amphetamines14 March 2022 | Pulmonary Circulation, Vol. 12, No. 1No Good Deed Goes UnpunishedChest, Vol. 159, No. 3Use of methylphenidate and risk for valvular heart disease: A case‐control study nested in the BIFAP cohort30 January 2020 | Pharmacoepidemiology and Drug Safety, Vol. 29, No. 3Amphetamine-induced sensitization of hypertension and lamina terminalis neuroinflammationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol. 318, No. 3Drug-associated pulmonary arterial hypertension6 March 2018 | Clinical Toxicology, Vol. 56, No. 9Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies10 May 2018 | Cochrane Database of Systematic Reviews, Vol. 48Stimulants and Pulmonary Arterial Hypertension: An UpdateAdvances in Pulmonary Hypertension, Vol. 17, No. 2Anorexigen-Associated Pulmonary Arterial Hypertension and the Serotonin Hypothesis: A Story Worth TellingAdvances in Pulmonary Hypertension, Vol. 17, No. 2Methylphenidate off-label use and safety7 June 2014 | SpringerPlus, Vol. 3, No. 1Updated Clinical Classification of Pulmonary HypertensionJournal of the American College of Cardiology, Vol. 62, No. 25Possible Association with Amphetamine Usage and Development of High Altitude Pulmonary EdemaWilderness & Environmental Medicine, Vol. 23, No. 4Consenso sobre la clasificación de la enfermedad vascular pulmonar hipertensiva en niños: Reporte del task force pediátrico del Pulmonary Vascular Research Institute (PVRI) Panamá 2011Revista Colombiana de Cardiología, Vol. 19, No. 6A Consensus Approach to the Classification of Pediatric Pulmonary Hypertensive Vascular Disease: Report from the PVRI Pediatric Taskforce, Panama 20111 April 2011 | Pulmonary Circulation, Vol. 1, No. 2 Volume 20Issue 3Jun 2010 InformationCopyright 2010, Mary Ann Liebert, Inc.To cite this article:Mehmet Goksin Karaman, Figen Atalay, Ali Evren Tufan, and Ayten Erdogan.Pulmonary Aterial Hypertension in an Adolescent Treated with Methylphenidate.Journal of Child and Adolescent Psychopharmacology.Jun 2010.229-231.http://doi.org/10.1089/cap.2009.0095Published in Volume: 20 Issue 3: June 26, 2010PDF download